» Articles » PMID: 15984932

Liver Fatty-acid-binding Protein (L-FABP) Gene Ablation Alters Liver Bile Acid Metabolism in Male Mice

Overview
Journal Biochem J
Specialty Biochemistry
Date 2005 Jun 30
PMID 15984932
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Although the physiological roles of the individual bile acid synthetic enzymes have been extensively examined, relatively little is known regarding the function of intracellular bile acid-binding proteins. Male L-FABP (liver fatty-acid-binding protein) gene-ablated mice were used to determine a role for L-FABP, the major liver bile acid-binding protein, in bile acid and biliary cholesterol metabolism. First, in control-fed mice L-FABP gene ablation alone increased the total bile acid pool size by 1.5-fold, especially in gall-bladder and liver, but without altering the proportions of bile acid, cholesterol and phospholipid. Loss of liver L-FABP was more than compensated by up-regulation of: other liver cytosolic bile acid-binding proteins [GST (glutathione S-transferase), 3alpha-HSD (3alpha-hydroxysteroid dehydrogenase)], key hepatic bile acid synthetic enzymes [CYP7A1 (cholesterol 7alpha-hydroxylase) and CYP27A1 (sterol 27alpha-hydroxylase)], membrane bile acid translocases [canalicular BSEP (bile salt export pump), canalicular MRP2 (multidrug resistance associated protein 2), and basolateral/serosal OATP-1 (organic anion transporting polypeptide 1)], and positive alterations in nuclear receptors [more LXRalpha (liver X receptor alpha) and less SHP (short heterodimer partner)]. Secondly, L-FABP gene ablation reversed the cholesterol-responsiveness of bile acid metabolic parameters such that total bile acid pool size, especially in gall-bladder and liver, was reduced 4-fold, while the mass of biliary cholesterol increased 1.9-fold. The dramatically reduced bile acid levels in cholesterol-fed male L-FABP (-/-) mice were associated with reduced expression of: (i) liver cytosolic bile acid-binding proteins (L-FABP, GST and 3alpha-HSD), (ii) hepatic bile acid synthetic enzymes [CYP7A1, CYP27A1 and SCP-x (sterol carrier protein-x/3-ketoacyl-CoA thiolase)] concomitant with decreased positive nuclear receptor alterations (i.e. less LXRalpha and more SHP), and (iii) membrane bile acid transporters (BSEP, MRP2 and OATP-1). These are the first results suggesting a physiological role for the major cytosolic bile acid-binding protein (L-FABP) in influencing liver bile metabolic phenotype and gall-bladder bile lipids of male mice, especially in response to dietary cholesterol.

Citing Articles

Rice Protein Reduces Triglyceride Levels through Modulating CD36, MTP, FATP, and FABP Expression in Growing and Adult Rats.

Liu B, Wang Z, Liang M, Yang L Foods. 2024; 13(17).

PMID: 39272469 PMC: 11395578. DOI: 10.3390/foods13172704.


A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine.

Pelletier A, Pacheco Sanchez G, Izmirly A, Watson M, Di Pucchio T, Carvalho K Cell Rep. 2024; 43(7):114370.

PMID: 38900640 PMC: 11404042. DOI: 10.1016/j.celrep.2024.114370.


Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism.

Yabut K, Martynova A, Nath A, Zercher B, Bush M, Isoherranen N Mol Pharmacol. 2024; 105(6):395-410.

PMID: 38580446 PMC: 11114116. DOI: 10.1124/molpharm.124.000878.


Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein (FABP1) and FABP1 Binding Alters Drug Metabolism.

Yabut K, Martynova A, Nath A, Zercher B, Bush M, Isoherranen N bioRxiv. 2024; .

PMID: 38293009 PMC: 10827205. DOI: 10.1101/2024.01.17.576032.


Advances in the study of subclinical AKI biomarkers.

Zou C, Wang C, Lu L Front Physiol. 2022; 13:960059.

PMID: 36091391 PMC: 9449362. DOI: 10.3389/fphys.2022.960059.


References
1.
Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T . Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 1998; 12(8):1189-201. PMC: 316706. DOI: 10.1101/gad.12.8.1189. View

2.
Carey M . Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res. 1978; 19(8):945-55. View

3.
Puglielli L, Rigotti A, Amigo L, Nunez L, Greco A, Santos M . Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile. Biochem J. 1996; 317 ( Pt 3):681-7. PMC: 1217540. DOI: 10.1042/bj3170681. View

4.
Meier P, Stieger B . Bile salt transporters. Annu Rev Physiol. 2002; 64:635-61. DOI: 10.1146/annurev.physiol.64.082201.100300. View

5.
Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View